Latest Conference Articles

Treatment of the relapsing form of multiple sclerosis has come a long way in recent years. The hope by researchers now is that treatment for progressive multiple sclerosis could be coming up sooner rather than later.

Pain levels due to diabetic peripheral neuropathy (DPN) may be altered depending on patients' vitamin D levels, a British study. The findings will be presented in a poster session on June 8 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.

Generic drugs used to be the cheaper alternative to name brand drugs. Now they are sometimes more expensive. The blame could go to Wall Street, the Obama administration, or even pharma collusion, but someone better put a stop to the increases, AMA delegates agreed today.

DPP-4 inhibitors may also enhance beta cell function in patients with type 2 diabetes mellitus.

Diabetes researchers looked at the impact of chronic kidney disease on the glucose-regulating drug empagliflozin.

Results from a 104-week phase 3 study may have important implications for the way patients with type 2 diabetes mellitus tackle weight loss.

Insulin glargine, a commonly used treatment for type 2 diabetes mellitus, may be more effective when administered at a higher dose, according to results from a phase 3 study.

While medications go through extensive studies and research before being released to patients, the results in a controlled setting versus real-life situations may vary. Or do they?

Study results show that the combination of metformin and glibenclamide is as effective as insulin in achieving glycemic control in women with gestational diabetes and may be a more acceptable and cost effective therapy.

Researchers compared canagliflozin and sitagliptin treatment on HbA1c levels and body weight in patients with type 2 diabetes mellitus.

A rat study shows saxagliptin has promise for renal protection.

Empagliflozin, a diabetes drug that controls glucose levels, may also help ameliorate erectile dysfunction in patients with type 2 diabetes mellitus.

Approved by the US Food and Drug Administration (FDA) just over 4 years ago, linagliptin (Tradjenta) can help protect against renal injury in patients with type 2 diabetes.

Oxidative stress plays an important role in the ability for dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, to effectively ease diabetic nephropathy, according to lead author Takashi Hatanaka of Nagoya University. The study will be presented in a poster session on June 6 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.

When treating elderly patients going under the knife may not always be the ideal solution to a problem. However, in some cases it may be the only option to ensuring a high quality of life for patients.

Changing the way medicine approaches a topic, especially a sensitive one like treating older patients is never easy. However, with more patients living well into their 70s and beyond it is becoming an increasingly important area of care.

Thanks to modern science people are living longer than they ever have before. While that is a positive in many ways it is also presenting new challenges to healthcare professionals in a variety of fields.

A growing trend in the medical community is the use of a technique known as mindfulness based stress reduction. While the results have shown to be inconclusive in the treatment of multiple sclerosis there is work being done to show its efficacy in helping patients.

Patients with multiple sclerosis face stress from a variety of sources. How they address that stress can make a significant difference in their overall quality of life.

When looking at ways to help patients with multiple sclerosis, one alternative method to use could be progressive muscle relaxation.

There can be specific times when patients with multiple sclerosis can experience a spike in their stress level. At times like these alternative medicine options like guided imagery can help reduce their stress as the progress through treatment.

The American Medical Association's 538 delegates will convene in Chicago, Il June 6-10. Vaccination policy, the ethics of doctors promoting unproven remedies, transgender military medical care, and are sunglasses sufficiently regulated are just of few of the 250 topics due to come up for discussion.

Previous studies have suggested that patients with multiple sclerosis may not be able to handle a high intensity weight training program. One recent work has shown that may not be the case.

Work has been done to look at what potential benefit robotics could have on patient care for people with multiple sclerosis. While the research looks promising, bringing the technology to the people is still far on the horizon.

Treating multiple sclerosis requires the work of a number of people. One of the key members of that team is the nurse. Specially trained nurses can help ease the burden of doctors while also providing needed help to patients.

On the long list of concerns patients with multiple sclerosis have to deal with on a daily basis their sexual health may not be high on the list of priorities. By having a conversation it can be an obstacle that can be overcome.

Up to 90 percent of patients with multiple sclerosis have spinal cord pathology.

Experimental stem cell therapy using a patient's own stem cells could offer long-term relief for many patients with multiple sclerosis, though questions still remain regarding cost, patient selection, and efficacy.

When many people think of ballroom dancing they likely think of Fred Astaire and Ginger Rogers. The same steps that made them famous on the big screen could help people stay on their feet despite the challenges of multiple sclerosis.

One of the biggest concerns about patients with multiple sclerosis is their potential to have movement limited by the condition. Researchers are looking for ways to stop that from happening.